IFNG and neoplasm: Because acidic condition enhances the release of drugs by CREKA-lipo nanoparticles 8, 31, when CREKA-lipo-anti-IFNγ was delivered into the tumour, the tumour acidic environment will elicit the local release of anti-IFNγ antibodies by the nanoparticles.